Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Market Outlook 2016-2021
- GEN713958
- 103 Pages
- September 2016
- Pharmaceuticals
Spiramycin has been used in Europe since the year 2000 under the trade name "Rovamycine", produced by Rhone-Poulenc Rorer and Famar Lyon, France and Eczacibasi Ilae, Turkey. It also goes under the name Rovamycine in Canada (distributed by OdanLaboratories), where it is mostly marketed to dentists for mouth infections.
Spiramycin is a 16-membered ring macrolide. It was discovered in 1952 as a product of Streptomyces ambofaciens. As a preparation for oral administration it has been used since 1955, in 1987 also the parenteral form was introduced into practice. The antibiotic action involves inhibition of protein synthesis in the bacterial cell during translocation. Resistance to spiramycin can develop by several mechanisms and its prevalence is to a considerable extent proportional to the frequency of prescription in a given area. The antibacterial spectrum comprises Gram-positive cocci and rods, Gram-negative cocci and also Legionellae, mycoplasmas, chlamydiae, some types of spirochetes, Toxoplasma gondii and Cryptosporidium species. Enterobacteria, pseudomonads and pathogenic moulds are resistant. Its action is mainly bacteriostatic, on highly sensitive strains it exerts a bactericide action. As compared with erythromycin, it is in vitro weight for weight 5 to 20 less effective, an equipotential therapeutic dose is, however, only double. This difference between the effectiveness in vitro and in vivo is explained above all by the great affinity of spiramycin to tissues where it achieves concentrations many times higher than serum levels. An important part is played also by the slow release of the antibiotic from the tissue compartment, the marked action on microbes in sub-inhibition concentrations and the relatively long persisting post-antibiotic effect. Its great advantage is the exceptionally favourable tolerance-gastrointestinal and general. It is available for parenteral and oral administration
This report provides detailed analysis of worldwide markets for Spiramycin Base (Spiramycin) (CAS 8025-81-8) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Spiramycin Base (Spiramycin) (CAS 8025-81-8) market and further lays out an analysis of the factors influencing the supply/demand for Spiramycin Base (Spiramycin) (CAS 8025-81-8), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Spiramycin Base (Spiramycin) (CAS 8025-81-8) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Spiramycin Base (Spiramycin) (CAS 8025-81-8) market are Sanofi-Aventis (France), CLL Pharma (Italy), TOPFOND (China), Fortune Pharmaceutical (China), among others.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Spiramycin Base (Spiramycin) (CAS 8025-81-8) industry has been provided.
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario
Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application
Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies
Part 10 Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments
List Of Tables
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Volume (Unit) 2011-2016
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value (M USD) 2011-2016
Figure Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Volume Share 2015
Figure Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value Share 2015
Figure Regional Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) 2015
Figure Regional Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Spiramycin Base (Spiramycin) (CAS 8025-81-8) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2011-2016
Table Global Key Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Share 2011-2016
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2011-2016
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2011
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2012
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2013
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2014
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2015
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production (Unit) 2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Spiramycin Base (Spiramycin) (CAS 8025-81-8) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Spiramycin Base (Spiramycin) (CAS 8025-81-8) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Spiramycin Base (Spiramycin) (CAS 8025-81-8) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Spiramycin Base (Spiramycin) (CAS 8025-81-8) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value (M USD), Growth Rate
Table Global Key Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2011-2016
Table Global Key Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value Share 2011-2016
Figure Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2011
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2012
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2013
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2014
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2015
Table Global Top 10 Spiramycin Base (Spiramycin) (CAS 8025-81-8) Vendors Production Value (M USD) 2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Prices (USD/Ton) 2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Gross Margin 2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value (M USD) By Region 2011-2016
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value (M USD) 2011-2016
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Value Share Trend
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2015
Table Regional Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2011-2016
Table Regional Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume Share 2011-2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption in North America 2011-2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption in EMEA 2011-2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption in Asia-Pacific 2011-2016
Figure Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption in ROW 2011-2016
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2016
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2011-2016
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume Share 2011-2016
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) Forecast 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production Share 2016-2021
Figure North Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) Forecast 2016-2021
Figure EMEA Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) Forecast 2016-2021
Figure ROW Spiramycin Base (Spiramycin) (CAS 8025-81-8) Production (Unit) Forecast 2016-2021
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) Forecast 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue Share 2016-2021
Figure North America Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) Forecast 2016-2021
Figure EMEA Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) Forecast 2016-2021
Figure ROW Spiramycin Base (Spiramycin) (CAS 8025-81-8) Revenue (M USD) Forecast 2016-2021
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume Share 2016-2021
Figure North America Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption (Unit) Forecast
Figure EMEA Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption (Unit) Forecast
Figure Asia-Pacific Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption (Unit) Forecast
Figure ROW Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption (Unit) Forecast
Figure Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume (Unit) 2016-2021
Table Global Spiramycin Base (Spiramycin) (CAS 8025-81-8) Consumption Volume Share 2016-2021
Table Key Strategies for Spiramycin Base (Spiramycin) (CAS 8025-81-8) Multinational Corporations
Table Key Strategies for Spiramycin Base (Spiramycin) (CAS 8025-81-8) Emerging-Market Players
List Of Figures
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
